Russia Parenteral Nutrition Market is Estimated at a Record USD 321.4 Million by the End of 2030 | Infinium Global Research

The Russia Parenteral Nutrition Market is witnessing significant growth, driven by a surge in gastrointestinal cancer cases and the aging population. A comprehensive market research report sheds light on the market dynamics, identifying key drivers, challenges, and opportunities. The Russia parenteral nutrition market was valued at USD 200.1 Million in 2022 and is expected to reach USD 321.4 Million by 2030 and grow at a CAGR of 6.27% over the forecast period.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/827

Rising Gastrointestinal Cancer Incidence Propels Market Demand

The prevalence of gastrointestinal cancer is on the rise in Russia, with stomach and colorectal cancers accounting for nearly 20% of cancer cases in 2018. Smoking, a significant risk factor for gastric cancer, is prevalent, with over 60% of men and 22% of women in Russia smoking. The growing incidence of gastrointestinal cancer, particularly in the upper part of the stomach near the esophagus, is anticipated to drive the demand for parenteral nutrition in Russia.

Aging Population Boosts Market Growth

Russia is expected to experience a significant increase in its aging population over the next few years. The government forecasts a decline of 10 million people of working age by 2033, leading to a rise in the elderly population. The geriatric population, prone to malnutrition, requires nutritional support, making parenteral nutrition a vital component in healthcare. The nutritional supplementation for the elderly is crucial for maintaining independence and managing debilitating diseases, contributing to the growth of the parenteral nutrition market.

Challenges in Parenteral Nutrition Usage

Despite its importance, parenteral nutrition formulations come with challenges and complications. Common complications include infection, abnormal glucose levels, and liver dysfunction. Additionally, there is a risk of adverse effects from excessive lipid administration, posing potential life-threatening complications. The prevalent use of enteral nutritional products and concerns about complications restrain the growth of the parenteral nutrition market.

Market Opportunities and Future Outlook

The development of third-generation lipids, including combinations of medium-chain triglycerides, olive oil, and omega-3 fatty acids derived from fish oil, presents an opportunity for market growth. These novel intravenous lipid products offer clinical benefits and aim to reduce complications associated with parenteral nutrition. Ongoing research into optimal compositions for parenteral nutrition formulations further supports market growth, especially in advanced cancer care and diseases associated with the aging population.

Key Players in the Russia Parenteral Nutrition Market

Leading players in the Russia parenteral nutrition market, including Baxter International Inc., Pfizer Inc., B. Braun Melsungen AG, Fresenius Kabi AG, and Sphera Pharma LLC, are at the forefront of addressing market dynamics. These companies are navigating challenges and leveraging opportunities to meet the growing demand for parenteral nutrition products.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/827

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Parenteral Nutrition Market Highlights

2.2. Parenteral Nutrition Market Projection

2.3. Parenteral Nutrition Market Regional Highlights

Chapter 3. Global Parenteral Nutrition Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Analysis of COVID-19 impact on the Parenteral Nutrition Market

3.4. Porter's Five Forces Analysis

3.5. IGR-Growth Matrix Analysis

3.5.1. IGR-Growth Matrix Analysis by Nutrient Type

3.5.2. IGR-Growth Matrix Analysis by Dosage Form

3.5.3. IGR-Growth Matrix Analysis by End-User

3.5.4. IGR-Growth Matrix Analysis by Region

3.6. Value Chain Analysis of Parenteral Nutrition Market

Chapter 4. Parenteral Nutrition Market Macro Indicator Analysis

Chapter 5. Global Parenteral Nutrition Market by Nutrient Type

5.1. Carbohydrates

5.2. Amino Acids

5.3. Lipids

5.4. Electrolytes

5.5. Others (Multivitamin Formulations and Trace Elements)

Chapter 6. Global Parenteral Nutrition Market by Dosage Form

6.1. Bags

6.2. Vials

6.3. Ampules

6.4. Bottles

Chapter 7. Global Parenteral Nutrition Market by End User

7.1. Clinics

7.2. Hospitals

7.3. Others

Chapter 8. Global Parenteral Nutrition Market by Region 2023-2030

8.1. North America

8.1.1. North America Parenteral Nutrition Market by Nutrient Type

8.1.2. North America Parenteral Nutrition Market by Dosage Form

8.1.3. North America Parenteral Nutrition Market by End User

8.1.4. North America Parenteral Nutrition Market by Country

8.2. Europe

8.2.1. Europe Parenteral Nutrition Market by Nutrient Type

8.2.2. Europe Parenteral Nutrition Market by Dosage Form

8.2.3. Europe Parenteral Nutrition Market by End User

8.2.4. Europe Parenteral Nutrition Market by Country

8.3. Asia-Pacific

8.3.1. Asia-Pacific Parenteral Nutrition Market by Nutrient Type

8.3.2. Asia-Pacific Parenteral Nutrition Market by Dosage Form

8.3.3. Asia-Pacific Parenteral Nutrition Market by End User

8.3.4. Asia-Pacific Parenteral Nutrition Market by Country

8.4. RoW

8.4.1. RoW Parenteral Nutrition Market by Nutrient Type

8.4.2. RoW Parenteral Nutrition Market by Dosage Form

8.4.3. RoW Parenteral Nutrition Market by End User

8.4.4. RoW Parenteral Nutrition Market by Sub-region

Chapter 9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Parenteral Nutrition Market

9.2. Companies Profiles

9.2.1. B. Braun Melsungen AG

9.2.2. Fresenius Kabi AG

9.2.3. Allergan Plc

9.2.4. Grifols, S.A.

9.2.5. Pfizer, Inc. (Hospira)

9.2.6. Otsuka Pharmaceutical Factory, Inc.

9.2.7. Baxter International, Inc.

9.2.8. Sichuan Kelun Pharmaceutical Co., Ltd

9.2.9. Vifor Pharma

9.2.10. Aculife (Nirlife)

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/827

Reasons to Buy this Report:

=> Comprehensive analysis of regional markets of parenteral nutrition.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.